Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma
Clinical trial NCT06933394 · RECRUITING
Trial details
- NCT number
- NCT06933394
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2031-05-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.